Owens & Minor | AI Transformation Index

Owens & Minor P&HS is a physical-infrastructure-anchored business whose durability rests on what AI cannot do — operate a national distribution network for...

Owens & MinorHealthcare (Medical - Distribution)Platinum Equity

Overview

Owens & Minor P&HS is a national distributor of medical and surgical supplies to acute care facilities, generating revenue through cost-plus and transaction-based pricing on the procurement, warehousing, and fulfillment of clinical products to hospitals and health systems.

Executive Summary

Owens & Minor P&HS is a physical-infrastructure-anchored business whose durability rests on what AI cannot do — operate a national distribution network for regulated medical products — rather than on cognitive moats that AI threatens. The AI opportunity is genuine but bounded: optimization of demand forecasting, inventory management, and back-office workflows can improve economics in a structurally thin-margin business, but this is an operational improvement story rather than a transformative step-change. For Platinum Equity, the value creation thesis should center on operational excellence and supply chain efficiency rather than AI-driven business model transformation; the business is durable but the AI upside is incremental.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

8

Profit Pool Migration

5

Barrier to Entry

7

Disintermediation Exposure

5

Switching Costs

6
Total62.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

5

Improvement Magnitude

6

Transformation Upside

4

Domain Intelligence Amplification

4
Total47.5

54.3

Ciridae AI Score

Durability Rationale

Owens & Minor P&HS is structurally durable in the most fundamental sense: AI cannot put a box of sutures in a hospital's storeroom. The physical infrastructure — national distribution network, warehouse footprint, cold-chain compliance, regulatory product handling — creates barriers that AI-native entrants cannot bypass with software alone. The real durability questions are about margin and disintermediation: the distributor sits in a historically thin-margin middle layer subject to persistent pressure from GPOs, large IDNs, and potential direct-sourcing alternatives; AI accelerates the commoditization of the coordination and information work that used to justify the distributor's margin premium, even as it cannot substitute the physical execution. Switching costs and workflow integration provide a meaningful but imperfect defense.

Opportunity Rationale

The AI opportunity for Owens & Minor P&HS is real but structurally bounded by the physical nature of the business — the highest-value workflows (demand forecasting, inventory optimization, procurement intelligence, customer service automation) are AI-applicable and could meaningfully improve unit economics in a low-margin distribution business where every basis point matters. However, unlike a pure cognitive-labor business, AI cannot remove the physical constraint on throughput or fundamentally transform the cost structure; the step-change is operational improvement, not business model reinvention. The domain intelligence that exists is more rules-based and codifiable than deeply experiential, limiting the amplification thesis.

Key Risks

If large IDNs and health systems accelerate self-distribution capabilities — potentially AI-augmented — the distributor middle layer could face sharper margin compression than the physical infrastructure moat implies, making the durability case weaker than the asset base suggests.

If the cognitive workflows in distribution (forecasting, procurement, inventory) are already well-served by existing supply chain software vendors (Oracle, SAP, Blue Yonder), the incremental AI opportunity may be smaller than it appears — the unrealized step-change may already be partially captured by incumbent enterprise software, not by AI transformation.

Company Overview

HeadquartersRichmond, Virginia, USA
Products / Services
Medical and surgical supplies distribution, infection prevention products, and healthcare services to acute care providers.
Deal Partners

PE / Ownership History

EventDetails
Platinum Equity acquired the Products & Healthcare Services (P&HS) segment from Owens & Minor.
December 31, 2025
The acquisition was valued at $375 million in cash, with Owens & Minor retaining a 5% equity stake. The P&HS business continues to operate as Owens & Minor P&HS as a privately held standalone company within Platinum Equity's portfolio.
Owens & Minor announced the definitive agreement to divest the Products & Healthcare Services (P&HS) segment to Platinum Equity.
October 2025
The agreement was for $375 million in cash and a retained equity stake. The remaining Owens & Minor business rebranded as Accendra Health, Inc.

Executives

NameBackground
Christian Cook
Chairman and Interim CEO
Managing Director at Platinum Equity
Jonathan A. Leon
Executive Vice President & Chief Financial Officer
Previously spent 18 years at The Brink’s Company in treasury and investor relations roles.
Perry A. Bernocchi
Executive Vice President & Chief Operating Officer
CEO of the Patient Direct segment since March 2023.
Dirk Benson
Chief Commercial Officer
Over 30 years of experience in healthcare supply chain manufacturing and distribution. Previously, President of U.S. Distribution Business for Henry Schein and senior leadership roles at Medline Industries.
Jennifer Stone
Executive Vice President, Chief Human Resources Officer
Based in Andover, MN.
Greg Sagstetter
Senior Vice President, Deputy General Counsel
Based in Richmond, VA.
Andrew G. Long
EVP and CEO, Products and Healthcare Services
Former EVP, CEO of Products & Healthcare Services
Michael W. Lowry
Senior VP, Corporate Controller & Chief Accounting Officer
Former Senior VP, Corporate Controller & Chief Accounting Officer
Jillian Barden
Senior Vice President - Finance - Products and Healthcare Services (Segment CFO)
N/A
Dean Huibregtse
Senior Vice President, Commercial Sales
N/A
Janice Tucciarone
Vice President Marketing and Communications
N/A
Deanna Lahey
Senior Vice President, Enterprise Operations and Patient Direct
N/A